Physician

Burhan S Yanes, MD

According to 2025 Medicare claims, Burhan Yanes, MD (NPI: 1275572869) practices hematology/oncology in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is DAYTON PHYSICIANS, LLC (NPI: 1902844947; TIN: 203130844) and primary practice location at 45409-1328. Yanes is affiliated with the Health Centers of Ohio ACO LLC (ACO ID: A5411), participating under the MSSP model.

Yanes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 464 traditional Medicare patients, billed 109,824 HCPCS/CPT codes, and received $2,096,978 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 633 prescription claims across 135 beneficiaries totaling $1,924,131 in drug costs, led by Xtandi (Enzalutamide). 2023 DME data shows 58 claims. Open Payments data shows 98 records totaling $2,957. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $836,323 and ending at $2,096,978. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $996,514 and ending at $1,924,131. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,357 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.3M2015 Medicare payment: $836,323 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,420,387 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,504,311 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,602,673 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,253,373 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,721,079 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,639,276 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,346,490 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,520,993 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,096,978 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201544370,001$836,323
201649599,336$1,420,387
201756697,066$1,504,311
201858994,850$1,602,673
2019677130,515$2,253,373
2020527106,469$1,721,079
202150995,836$1,639,276
202251786,265$1,346,490
2023507103,008$1,520,993
2024464109,824$2,096,978

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.2M2015 Drug cost: $996,514 (USD; Tot_Drug_Cst)2016 Drug cost: $1,905,211 (USD; Tot_Drug_Cst)2017 Drug cost: $2,007,191 (USD; Tot_Drug_Cst)2018 Drug cost: $1,965,615 (USD; Tot_Drug_Cst)2019 Drug cost: $1,532,190 (USD; Tot_Drug_Cst)2020 Drug cost: $1,735,683 (USD; Tot_Drug_Cst)2021 Drug cost: $2,242,311 (USD; Tot_Drug_Cst)2022 Drug cost: $1,956,345 (USD; Tot_Drug_Cst)2023 Drug cost: $1,748,978 (USD; Tot_Drug_Cst)2024 Drug cost: $1,924,131 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015149696$996,514
2016175998$1,905,211
2017150860$2,007,191
2018130620$1,965,615
2019128568$1,532,190
2020114629$1,735,683
2021138903$2,242,311
2022133716$1,956,345
2023164781$1,748,978
2024135633$1,924,131

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$7.7K$15K2015 Medicare payment: $5,314 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $13,160 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $6,776 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,376 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $949 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $15,428 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R51$5,314
2016N/RN/RN/R
2017N/R76$13,160
2018N/R36$6,776
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R37$3,376
2022N/R28$949
2023N/R58$15,428
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more58151$136
96413Administration of chemotherapy into vein, 1 hour or less81263$96
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more172332$92
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's92187$13
96375Injection of additional new drug or substance into vein61205$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide341,020$427,121
LenalidomideLenalidomide26728$334,138
IbrancePalbociclib17476$248,244
ImbruvicaIbrutinib11326$180,370
EliquisApixaban18960$18,141

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.98$2,957Daiichi Sankyo Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Burhan S. Yanes, MD?

Tedicare shows public-source Medicare data for Burhan S. Yanes, MD (NPI 1275572869), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Burhan S. Yanes, MD have ACO affiliation data?

Burhan S. Yanes, MD is shown with ACO affiliation data for Health Centers of Ohio ACO LLC (MSSP, ACO ID A5411).

What billing organization is linked to Burhan S. Yanes, MD?

Burhan S. Yanes, MD is linked to DAYTON PHYSICIANS, LLC (billing NPI 1902844947) in the available physician profile data.

Does Burhan S. Yanes, MD have Open Payments data?

Burhan S. Yanes, MD has 98 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.